1. Home
  2. Labeler Index
  3. Carilion Materials Management
  4. 68151-4459
  5. Product Images: Aripiprazole

Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Label Image - 68151 4459
  2. Figure 3 - aripiprazole 3figure
  3. Figure 1 - aripiprazole figure1
  4. Figure 2 - aripiprazole figure2
  5. Figure 4 - aripiprazole figure4
  6. Figure 5 - aripiprazole figure5
  7. Figure 6 - aripiprazole figure6
  8. Structure - aripiprazole str
  9. Trigen Laboratories LLC - aripiprazole trigen

Product Label Images

The following 9 images provide visual information about the product associated with Aripiprazole NDC 68151-4459 by Carilion Materials Management, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Image - 68151 4459

Label Image - 68151 4459

Figure 3 - aripiprazole 3figure

Figure 3 - aripiprazole 3figure

Figure 1 - aripiprazole figure1

Figure 1 - aripiprazole figure1

This is a table displaying the effect of various drugs on the concentration of aripiprazole. The drugs include CYP1A and CYP2D inhibitors, VP34 inducer, Gastric Acid Blockers, and Vlproate. The table shows the fold change and 90% CI for each drug, as well as the maximum concentration for certain drugs.*

Figure 2 - aripiprazole figure2

Figure 2 - aripiprazole figure2

Figure 4 - aripiprazole figure4

Figure 4 - aripiprazole figure4

This appears to be a partial table of data related to pharmacokinetics (how drugs are processed by the body) of a drug called "Arpiprazole" on special populations, such as those with hepatic (liver) or renal (kidney) impairment. It also indicates the effect of age, gender, and metabolizer status on the drug's concentration in the body. However, without more context or a complete table, it is difficult to understand the full implications of these findings.*

Figure 5 - aripiprazole figure5

Figure 5 - aripiprazole figure5

Figure 6 - aripiprazole figure6

Figure 6 - aripiprazole figure6

This appears to be a graph or table showing the proportion of subjects with relapse for a drug called "Arpiprazole" compared to a placebo, with the number of subjects at risk listed below. The x-axis appears to show the number of days from randomization. No further information is available.*

Structure - aripiprazole str

Structure - aripiprazole str

Trigen Laboratories LLC - aripiprazole trigen

Trigen Laboratories LLC - aripiprazole trigen

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.